Know Cancer

or
forgot password

    • cancer clinical trials in nashville, TN

    • Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
    Saint Thomas Hospital
    Nashville, Tennessee 37205
    Lung Cancer
    Vaccine Therapy for Patients With Stage IV Melanoma
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Malignant Melanoma
    Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Childhood Lymphocyte Predominant Hodgkin Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage II Childhood Hodgkin Lymphoma
    S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Melanoma (Skin)
    Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
    MBCCOP - Meharry Medical College - Nashville

    Trial Locations
    MBCCOP - Meharry Medical College - Nashville
    Nashville Oncology Associates, P.C.
    Breast Cancer
    Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
    Baptist Hospital

    Trial Locations
    Baptist Hospital
    Sarah Cannon Cancer Center at Centennial Medical Center
    Breast Cancer
    Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
    Vanderbilt Therapeutics CRS
    Nashville, Tennessee 37204
    HIV Infections, Sexually Transmitted Diseases
    Combination Chemotherapy in Treating Children With Lymphoma
    Vanderbilt Cancer Center
    Nashville, Tennessee 37232-6838
    Lymphoma
    Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During Surgery
    Vanderbilt Cancer Center

    Trial Locations
    Vanderbilt Cancer Center
    Veterans Affairs Medical Center - Nashville
    Head and Neck Cancer
    Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease
    Vanderbilt Cancer Center
    Nashville, Tennessee 37232-6838
    Cardiac Toxicity, Lymphoma
    Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck
    Vanderbilt Cancer Center
    Nashville, Tennessee 37232-6838
    Head and Neck Cancer
    Evaluation of Breast Cancer Recurrence Rates Following Surgery in Women With Ductal Carcinoma In Situ
    Vanderbilt-Ingram Cancer Center

    Trial Locations
    Vanderbilt-Ingram Cancer Center
    Veterans Affairs Medical Center - Tennessee Valley Healthcare System - Nashville Campus
    Breast Cancer
    Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum
    Brookview Research, Inc.
    Nashville, Tennessee 37203
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer
    Vanderbilt-Ingram Cancer Center

    Trial Locations
    Vanderbilt-Ingram Cancer Center
    Veterans Affairs Medical Center - Tennessee Valley Healthcare System - Nashville Campus
    Gastric Cancer
    Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases
    Vanderbilt Cancer Center
    Nashville, Tennessee 37232-6838
    Metastatic Cancer
    Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors
    Vanderbilt Cancer Center
    Nashville, Tennessee 37232-6838
    Cancer
    Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
    Vanderbilt Cancer Center
    Nashville, Tennessee 37232-6838
    Bladder Cancer
    Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Fever, Sweats, and Hot Flashes, Neutropenia, Unspecified Childhood Solid Tumor, Protocol Specific
    Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors
    Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center
    Nashville, Tennessee 37232-2516
    Melanoma (Skin), Neuroblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome
    Vanderbilt Cancer Center
    Nashville, Tennessee 37232-6838
    Leukemia, Myelodysplastic Syndromes
    Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Leukemia, Myelodysplastic Syndromes, Sarcoma
    Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer
    Vanderbilt-Ingram Cancer Center

    Trial Locations
    Vanderbilt-Ingram Cancer Center
    Sarah Cannon-Minnie Pearl Cancer Center
    Baptist Hospital
    Breast Cancer
    STI571 in Treating Patients With Recurrent Leukemia
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Leukemia
    Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
    Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center
    Nashville, Tennessee 37232-2516
    Prostate Cancer
    Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus
    Vanderbilt Cancer Center
    Nashville, Tennessee 37232-6838
    Esophageal Cancer, Gastric Cancer
    ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment
    Sarah Cannon-Minnie Pearl Cancer Center
    Nashville, Tennessee 37203
    Fallopian Tube Cancer, Metastatic Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Brain and Central Nervous System Tumors
    Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therap
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Unspecified Childhood Solid Tumor, Protocol Specific
    Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Brain and Central Nervous System Tumors
    Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Cognitive/Functional Effects, Metastatic Cancer, Radiation Toxicity
    Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
    Vanderbilt-Ingram Cancer Center

    Trial Locations
    Vanderbilt-Ingram Cancer Center
    St. Thomas Medical Center
    Colorectal Cancer
    Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Head and Neck Cancer
    Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
    Vanderbilt-Ingram Cancer Center

    Trial Locations
    Vanderbilt-Ingram Cancer Center
    Tennessee Oncology, P.L.L.C.
    Colorectal Cancer
    Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
    Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center
    Nashville, Tennessee 37232-2516
    Prostate Cancer
    Research Study of Visilizumab for Treatment of Glucocorticoid- Refractory Graft Versus Host Disease
    Vanderbilt University Medical Center
    Nashville, Tennessee 37232-2516
    Graft-vs-Host Disease
    Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Vanderbilt-Ingram Cancer Center

    Trial Locations
    Vanderbilt-Ingram Cancer Center
    Veterans Affairs Medical Center - Tennessee Valley Healthcare System - Nashville Campus
    Multiple Myeloma and Plasma Cell Neoplasm
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Nashville Oncology Associates, PC
    Nashville, Tennessee 37203
    Breast Cancer